Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

186.18

+1.44 (0.78%)

At close: Feb 19, 2026, 4:00 PM EST

187.49

+1.31 (0.71%)

After-hours: Feb 19, 2026, 7:50 PM EST

Axsome Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	9,386	4,100	3,766	3,349	1,424	3,042
Market Cap Growth	80.27%	8.88%	12.44%	135.22%	-53.20%	-20.03%
Enterprise Value	9,279	3,965	3,535	3,216	1,359	2,888
Last Close Price	186.18	84.61	79.59	77.13	37.78	81.47
PS Ratio	16.72	10.63	13.92	66.94	-	-
PB Ratio	127.04	71.92	19.72	30.57	91.10	26.74
P/TBV Ratio	479.86	-	29.97	84.61	91.10	26.74
EV/Sales Ratio	16.53	10.28	13.06	64.28	-	-
Debt / Equity Ratio	2.97	3.38	0.98	0.86	3.18	0.44
Net Debt / Equity Ratio	-1.45	-2.15	-1.05	-0.97	-2.35	-1.17
Net Debt / EBITDA Ratio	0.57	0.50	1.14	0.62	0.30	1.35
Net Debt / FCF Ratio	1.05	0.95	1.37	0.91	0.34	1.70
Asset Turnover	0.91	0.67	0.59	0.24	-	-
Inventory Turnover	2.40	2.16	2.68	-	-	-
Quick Ratio	1.45	1.99	3.46	2.47	3.75	7.85
Current Ratio	1.57	2.11	3.63	2.54	3.75	7.85
Return on Equity (ROE)	-275.50%	-231.63%	-159.21%	-298.97%	-201.51%	-70.36%
Return on Assets (ROA)	-19.79%	-27.28%	-24.86%	-52.30%	-56.91%	-30.46%
Return on Capital Employed (ROCE)	-63.10%	-74.60%	-40.70%	-74.70%	-192.70%	-60.90%
Earnings Yield	-2.45%	-7.00%	-6.35%	-5.59%	-9.16%	-3.38%
FCF Yield	-1.08%	-3.14%	-3.87%	-3.50%	-7.62%	-2.58%
Buyback Yield / Dilution	-3.38%	-5.48%	-11.73%	-8.07%	-1.11%	-9.37%

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q